Variant report

Variant	rs4744177
Chromosome Location	chr9:95882226-95882227
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:8)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr9:95881490..95886849-chr9:95891631..95895235,6	K562	blood:
2	chr9:95880402..95885163-chr9:95893735..95897991,9	K562	blood:
3	chr9:95856611..95859611-chr9:95880855..95885285,4	K562	blood:
4	chr9:95856945..95860499-chr9:95877670..95883441,5	MCF-7	breast:
5	chr9:95872055..95874955-chr9:95880693..95882570,2	MCF-7	breast:
6	chr9:95874739..95878921-chr9:95879079..95884047,10	K562	blood:
7	chr9:95880402..95882338-chr9:95895350..95897991,3	K562	blood:
8	chr9:95874371..95880149-chr9:95880216..95885255,14	K562	blood:

No data

Variant related genes	Relation type
ENSG00000223446	Chromatin interaction
ENSG00000131669	Chromatin interaction
ENSG00000165233	Chromatin interaction

Extended variants
information (count: 26 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:18)

rs_ID	r²[population]
rs10114849	1.00[AFR][1000 genomes];0.81[AMR][1000 genomes]
rs10739943	0.81[AMR][1000 genomes]
rs1127851	0.85[JPT][hapmap];0.98[ASN][1000 genomes]
rs11793313	1.00[AFR][1000 genomes];0.93[AMR][1000 genomes];0.87[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs12378451	1.00[CHB][hapmap]
rs1419232	1.00[AFR][1000 genomes];0.81[AMR][1000 genomes]
rs1970623	1.00[CHB][hapmap]
rs2185974	0.84[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs2275848	0.85[JPT][hapmap];0.93[ASN][1000 genomes]
rs3750555	1.00[AFR][1000 genomes];0.93[AMR][1000 genomes];0.87[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs3793662	0.95[ASN][1000 genomes]
rs3829123	0.84[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs4743886	1.00[CHB][hapmap]
rs6479454	1.00[CHB][hapmap];0.85[JPT][hapmap];0.93[ASN][1000 genomes]
rs6479455	1.00[AFR][1000 genomes];0.81[AMR][1000 genomes]
rs7847349	1.00[AFR][1000 genomes];0.86[AMR][1000 genomes];0.84[EUR][1000 genomes]
rs7867718	1.00[AFR][1000 genomes];0.81[AMR][1000 genomes]
rs7875586	1.00[CHB][hapmap];0.85[JPT][hapmap];1.00[AFR][1000 genomes];0.93[AMR][1000 genomes];0.81[EUR][1000 genomes];0.96[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:8 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv526296	chr9:95708192-96030392	Enhancers Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	30 gene(s)	inside rSNPs	diseases
2	nsv1035230	chr9:95770249-95934982	Weak transcription Active TSS Flanking Active TSS Enhancers Genic enhancers Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	28 gene(s)	inside rSNPs	diseases
3	nsv893576	chr9:95789960-96158277	Active TSS Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	29 gene(s)	inside rSNPs	diseases
4	esv1824329	chr9:95811604-95921347	Strong transcription Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	23 gene(s)	inside rSNPs	diseases
5	nsv893578	chr9:95818641-95887320	Weak transcription Enhancers Strong transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Active TSS ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	17 gene(s)	inside rSNPs	diseases
6	nsv893579	chr9:95855100-95923091	Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	22 gene(s)	inside rSNPs	diseases
7	nsv893580	chr9:95855100-96099377	Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Genic enhancers Strong transcription Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	25 gene(s)	inside rSNPs	diseases
8	nsv893581	chr9:95872216-95930334	Enhancers Weak transcription Flanking Active TSS Strong transcription Genic enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	17 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:120 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:95859600-95889400	Weak transcription	Fetal Kidney	kidney
2	chr9:95870000-95895400	Weak transcription	H9 Cell Line	embryonic stem cell
3	chr9:95871000-95894200	Weak transcription	Dnd41	blood
4	chr9:95873400-95888800	Weak transcription	Placenta Amnion	Placenta Amnion
5	chr9:95873600-95886000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
6	chr9:95874800-95883600	Weak transcription	Primary T cells from cord blood	blood
7	chr9:95876600-95886000	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
8	chr9:95877000-95889200	Weak transcription	Fetal Brain Female	brain
9	chr9:95877200-95888800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
10	chr9:95877400-95883800	Weak transcription	Aorta	Aorta
11	chr9:95877400-95886000	Weak transcription	Brain Germinal Matrix	brain
12	chr9:95878400-95883400	Enhancers	Primary monocytes fromperipheralblood	blood
13	chr9:95878400-95885200	Enhancers	Primary B cells from cord blood	blood
14	chr9:95879000-95884000	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
15	chr9:95879000-95886000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
16	chr9:95879200-95882400	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
17	chr9:95879200-95882400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
18	chr9:95879200-95882600	Weak transcription	Brain Anterior Caudate	brain
19	chr9:95879200-95883800	Weak transcription	Brain Inferior Temporal Lobe	brain
20	chr9:95879200-95886000	Weak transcription	HUES48 Cell Line	embryonic stem cell
21	chr9:95879200-95886000	Weak transcription	iPS-15b Cell Line	embryonic stem cell
22	chr9:95879200-95886800	Weak transcription	HUES64 Cell Line	embryonic stem cell
23	chr9:95879200-95888600	Weak transcription	H1 Cell Line	embryonic stem cell
24	chr9:95879200-95889000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
25	chr9:95879400-95886000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
26	chr9:95880200-95883200	Enhancers	Spleen	Spleen
27	chr9:95881000-95882400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
28	chr9:95881000-95882400	Enhancers	Skeletal Muscle Male	skeletal muscle
29	chr9:95881000-95884000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
30	chr9:95881200-95882600	Enhancers	Skeletal Muscle Female	skeletal muscle
31	chr9:95881200-95883000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
32	chr9:95881200-95883000	Enhancers	Primary T helper cells fromperipheralblood	blood
33	chr9:95881200-95883000	Enhancers	Stomach Mucosa	stomach
34	chr9:95881200-95883200	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
35	chr9:95881200-95883200	Enhancers	Gastric	stomach
36	chr9:95881400-95882800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
37	chr9:95881400-95882800	Enhancers	Fetal Muscle Leg	muscle
38	chr9:95881400-95882800	Enhancers	NHLF	lung
39	chr9:95881400-95883200	Enhancers	Primary T cells fromperipheralblood	blood
40	chr9:95881400-95883200	Enhancers	Placenta	Placenta
41	chr9:95881400-95883600	Enhancers	Adipose Nuclei	Adipose
42	chr9:95881400-95883800	Enhancers	Brain Hippocampus Middle	brain
43	chr9:95881600-95882400	Enhancers	Fetal Stomach	stomach
44	chr9:95881600-95882400	Enhancers	Rectal Mucosa Donor 29	rectum
45	chr9:95881600-95882400	Enhancers	Rectal Smooth Muscle	rectum
46	chr9:95881600-95882600	Enhancers	Duodenum Mucosa	Duodenum
47	chr9:95881600-95882800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
48	chr9:95881600-95882800	Enhancers	Primary T regulatory cells fromperipheralblood	blood
49	chr9:95881600-95882800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
50	chr9:95881600-95882800	Enhancers	Brain Cingulate Gyrus	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links